Computer Adaptation of Screening, Brief MET Intervention to Reduce Teen Drinking
The goal of this project is to evaluate the feasibility, acceptability, and effect size of a new computerized Motivational Enhancement Therapy (cMET) intervention for alcohol-involved adolescents in primary care.
Tobacco Use Disorder
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||Computer Adaptation of Screening, Brief MET Intervention to Reduce Teen Drinking|
- Alcohol use [ Time Frame: up to 9-months follow-up ] [ Designated as safety issue: No ]The study investigators will measure the past 90 day alcohol use at 3-, 6-, and 9-months follow-up.
- Drinks per drinking day [ Time Frame: up to 9-months follow-up ] [ Designated as safety issue: No ]The study investigators will measure the number of drinks per drinking day in the past 90 days at 3-, 6-, and 9-months follow-up
- Heavy episodic drinking [ Time Frame: up to 9-months follow-up ] [ Designated as safety issue: No ]The study investigators will measure the occurrences of heavy episodic drinking in the past 90 days at 3-, 6-, and 9-months follow-up.
|Study Start Date:||January 2015|
|Estimated Study Completion Date:||August 2017|
|Estimated Primary Completion Date:||November 2016 (Final data collection date for primary outcome measure)|
No Intervention: Treatment As Usual
Those randomized to Treatment as Usual (TAU) will not complete cMET but will receive standard treatment from the doctor.
Those randomized to cMET will complete a 2-session computerized Motivational Enhancement Therapy (cMET) intervention.
Those in cMET complete the 2-session self-administered computerized intervention which includes 8 exercises designed to encourage adolescents to evaluate the impact of alcohol and other substance use on their health and well-being and consider changing their use.
Other Name: Computerized Motivational Enhancement Therapy intervention
The study aims are to:
- Assess cMET feasibility and acceptability and estimate its effect size on underage drinking. Hypothesis: Among 14- to 20-yr-old primary care patients, those receiving cMET will have lower rates of any alcohol use, days of alcohol use, drinks per drinking day, and days of heavy episodic drinking, than those receiving treatment as usual.
- Estimate effect sizes for tobacco, cannabis, and other drug use, and other substance-related risks and outcomes including substance-related driving/riding, and experience of substance-related problems.
- Identify potential moderators and mediators of cMET's effect.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01881841
|Contact: John R Knight, MDfirstname.lastname@example.org|
|United States, Massachusetts|
|Boston Children's Hospital||Recruiting|
|Boston, Massachusetts, United States, 02115|
|Contact: John R Knight, MD 617-355-5433 email@example.com|
|Contact: Melissa M Weiksnar, MS, MBA 857-218-4311 firstname.lastname@example.org|
|Principal Investigator: John R Knight, MD|
|Principal Investigator: Sion K Harris, PhD|
|Principal Investigator:||John R Knight, MD||Children's Hospital Boston|
|Principal Investigator:||Sion K Harris, PhD||Children's Hospital Boston|